Perturbed myoepithelial cell differentiation in mutation carriers and in ductal carcinoma in situ

Journal: Nature Communications

Published: 2019-09-13

DOI: 10.1038/s41467-019-12125-5

Affiliations: 34

Authors: 48

Go to article
Institutions Share
Sutter Roseville Medical Center, United States of America (USA) 0.11
Department of Medical Oncology, DFCI, United States of America (USA) 0.11
Baylor Charles A. Sammons Cancer Center at Dallas, United States of America (USA) 0.10
Johns Hopkins University School of Medicine (JHUSOM), JHU, United States of America (USA) 0.09
Harvard Department of Medicine, United States of America (USA) 0.06
Department of Medicine (DOM), BWH, United States of America (USA) 0.06
Lurie Family Imaging Center (LFIC), DFCI, United States of America (USA) 0.06
Center for Functional Cancer Epigenetics (CFCE), DFCI, United States of America (USA) 0.04
Yale Department of Biomedical Engineering, United States of America (USA) 0.03
Lawrence Berkeley National Laboratory (LBNL), United States of America (USA) 0.03
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.03
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Pathology, SNU, South Korea 0.02
Department of Cancer Biology, DFCI, United States of America (USA) 0.02
Department of Pathology, U-M, United States of America (USA) 0.02
Department of Pathology and Immunology, WUSTL, United States of America (USA) 0.02
Harvard Department of Genetics, United States of America (USA) 0.02
Department of Pathology, BWH, United States of America (USA) 0.02
Harvard Department of Pathology, United States of America (USA) 0.02
Cancer Treatment Centers of America (CTCA), United States of America (USA) 0.01
UNM School of Medicine (SOM), United States of America (USA) 0.01
EMEA Site Intelligence and Activation, Israel 0.01
Duke University, United States of America (USA) 0.01
Second Military Medical University (SMMU), China 0.01
Harvard Department of Stem Cell and Regenerative Biology (HSCRB), United States of America (USA) 0.01
Harvard Department of Biostatistics (BIO), United States of America (USA) 0.01
Department of Data Sciences, DFCI, United States of America (USA) 0.01
Graduate School / School of Medicine, Nagoya University, Japan 0.01
ImmunoGen, Inc., United States of America (USA) 0.01
WuXi NextCODE, United States of America (USA) 0.01
Metamark Genetics, Inc., United States of America (USA) 0.01
Deciphera Pharmaceuticals, Inc., United States of America (USA) 0.01
Harvard Stem Cell Institute (HSCI), United States of America (USA) 0

Return